Nicholas Investment Partners, LP - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 221 filers reported holding TRANSMEDICS GROUP INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$22,650,842
-26.6%
413,714
+12.5%
1.69%
-19.8%
Q2 2023$30,873,651
+11.0%
367,631
+0.1%
2.11%
-0.2%
Q1 2023$27,823,808
+55.6%
367,408
+26.8%
2.12%
+35.0%
Q4 2022$17,880,531
+54.3%
289,704
+4.4%
1.57%
+45.9%
Q3 2022$11,588,000277,6251.07%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q1 2023
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders